Cost-Effectiveness of Integrated Care in Patients with Chronic Kidney Disease Stage 3 and 4 Compared with Standard Care in Rural Communities

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.

Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.

Group M. Evaluation and management of chronic kidney disease : synopsis of the kidney disease : improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158:825-30.

Jiamjariyapon T, Ingsathit A, Pongpirul K, Vipattawat K, Kanchanakorn S, Saetie A, et al. Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study) : a cluster randomized controlled trial. BMC Nephrol 2017; 18:83.

Permsuwan U, Guntawongwan K, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thai 2014;97 Suppl 5:S50-8.

O’Brien RG, Muller KE. Applied analysis of variance in behavior science. 1983. New York: Maecel Dekker. p 297-344.

Palmer AJ, Valentine WJ, Chen R, Mehin N, Grabriel S, Bregman B, et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol Dial Transplant 2008, 23:1216-23.

World Health Organization. Cost effectiveness and strategic planning (WHO-CHOICE). [cited 2016 July 30]. Available from: http://www.who.int/choice/costs/CER_levels/en/#

Levin A, Lewis M, Mortiboy P, Faber S, Hare I, et al. Porter EC, Mendelssohn DC. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Cannadian settings. Am J Kidney Dis 1997;29:533-40.

Hopkins RB, Garg AX, Levin A, Molzahn A, Rigatto C, Singer J, et al. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clin J Am Soc Nephrol2011;6:1248-57.

Wei SY, Chang YY, Mau LW, Lin MY, Chiu HC, Tsai JC, et al. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology (Carlton)2010;15:108-15.

Lei CC, Lee PH, Hsu YC, Chang HY, Tung CW, Shih YH, et al. Educational intervention in CKD retards disease progression and reduces medical costs for patients with stage 5 CKD. Ren Fail 2013;35:9-16.

Sabariego C, Grill E, Brach M, Fritschka E, Mahlmeister J, Stucki G. Incremental cost-effectiveness analysis of a multidisciplinary renal education program for patients with chronic renal disease. Disabil Rehabil 2010; 32:392-401.